Product Overview: Femara 5 Nakon Medical
Femara 5mg Nakon Medical is a third-generation aromatase inhibitor containing letrozole as the active pharmaceutical ingredient. This non-steroidal compound functions as a potent and selective inhibitor of the aromatase enzyme (CYP19A1), which catalyses the final step in estrogen biosynthesis. Research institutions studying hormone-dependent cellular mechanisms utilise letrozole formulations to investigate estrogen synthesis pathways and their regulatory effects in various tissue models. The compound demonstrates exceptional selectivity for aromatase compared to other cytochrome P450 enzymes, making it a valuable tool for researchers examining estrogen-mediated cellular processes. Academic laboratories worldwide have incorporated letrozole into studies examining hormone-dependent gene expression, cellular proliferation pathways, and metabolic regulation in controlled research environments.
Laboratory Applications
Scientific research utilising Femara focuses on understanding aromatase enzyme kinetics and estrogen-dependent cellular signalling pathways. Molecular biology researchers examine how aromatase inhibition affects gene expression profiles in hormone-sensitive cell lines, particularly investigating transcriptional changes in estrogen receptor-positive models. Endocrinology research programmes study the compound’s effects on steroidogenesis pathways and feedback mechanisms within the hypothalamic-pituitary-gonadal axis using appropriate animal models. Pharmaceutical development teams analyse letrozole’s pharmacokinetic properties and metabolic pathways to understand drug-enzyme interactions and cellular uptake mechanisms. Cancer research laboratories investigate the compound’s role in hormone-dependent cellular growth models, examining how aromatase inhibition influences cellular proliferation markers and apoptotic pathways. Researchers at Stroid UK Shop can explore aromatase inhibitor research compounds alongside selective androgen receptor modulators and peptide research tools for comprehensive hormonal pathway investigations.
Technical Specifications
| Active Ingredient | Letrozole |
|---|---|
| Concentration | 5mg per tablet |
| CAS Number | 112809-51-5 |
| Molecular Formula | C₁₇H₁₁N₅ |
| Molecular Weight | 285.30 g/mol |
| Manufacturer | Nakon Medical |
| Storage Requirements | Room temperature, dry environment |
| Stability | 36 months sealed packaging |
Research Compliance
Femara 5mg Nakon Medical is supplied exclusively for in-vitro research applications and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional safety protocols and applicable regulations governing research chemical handling. All studies should be conducted by qualified personnel in appropriately equipped laboratory facilities with proper ventilation and safety equipment. This product is restricted to professional research use only and requires appropriate institutional oversight for all experimental applications.
